Forward News

Siemens and UCLA Get FDA "Green Light" for Study of Alzheimer's-Specific Imaging Agent

Study will measure the safety of one of the first imaging biomarkers designed to differentiate Alzheimer's disease from other forms of dementia.
From:   (your name)    (your email address) Forward To: 1. 2. 3. 4. 5.
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2009 DOTmed.com, Inc.
ALL RIGHTS RESERVED